Scarica l'app Stockscreener
79.03
1.97%
1.53
Kymera Therapeutics Inc Azioni (KYMR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
3.84%
2.87
|
2.764 | 11.48 | 22.10 | 7.394 |
| Cost Of Revenue |
3.84%
2.87
|
2.764 | 11.48 | 22.10 | - |
| Gross Profit |
-
|
- | - | - | - |
Operating Expenses
|
5.75%
100.77
|
95.28 | 96.03 | 96.53 | 88.15 |
| Benefits Costs and Expenses |
89.85
|
- | - | 87.68 | 78.15 |
| Costs And Expenses |
5.70%
89.85
|
95.28 | 96.03 | 87.68 | 78.15 |
| Operating Income/Loss |
5.81%
-97.90
|
-92.52 | -84.56 | -74.43 | -80.75 |
| Income/Loss From Continuing Operations Before Tax |
3,247%
-86.98
|
2.764 | 11.48 | -65.58 | -70.75 |
| Income/Loss From Continuing Operations After Tax |
5.85%
-86.98
|
-82.17 | -76.61 | -65.58 | -70.75 |
|
Net Income/Loss
|
5.85%
-86.98
|
-82.17 | -76.61 | -65.58 | -70.75 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
97.90%
1.8374
|
87.30 | 80.45 | 80.15 | 1.7137 |
| Diluted Average Shares |
97.90%
1.8374
|
87.30 | 80.45 | 80.15 | 1.7137 |
| Basic Earnings Per Share |
4.26%
-0.98
|
-0.94 | -0.95 | -0.82 | -0.89 |
| Diluted Earnings Per Share |
4.26%
-0.98
|
-0.94 | -0.95 | -0.82 | -0.89 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):